Activation of the mineralocorticoid receptor (MR) promotes inflammation, fibrosis, and hypertension. Clinical and experimental studies show that MR antagonists have significant therapeutic benefit for all-cause heart failure; however, blockade of renal MRs limits their widespread use. Identification of key downstream signaling mechanisms for the MR in the cardiovascular system may enable development of targeted MR antagonists with selectivity for pathological MR signaling and lower impact on physiological renal electrolyte handling. One candidate pathway is the circadian clock, the dysregulation of which is associated with cardiovascular diseases. We have previously shown that the circadian gene Per2 is dysregulated in hearts with selective deletion of cardiomyocyte MR. We therefore investigated MR-mediated cardiac inflammation and fibrosis in mice that lack normal regulation and oscillation of the circadian clock in peripheral tissues, that is, CLOCKD19 mutant mice. The characteristic cardiac inflammatory/fibrotic response to a deoxycorticosterone (DOC)/salt for 8 weeks was significantly blunted in CLOCKD19 mice when compared with wild-type mice, despite a modest increase at "baseline" for fibrosis and macrophage number in CLOCKD19 mice. In contrast, cardiac hypertrophy in response to DOC/salt was significantly greater in CLOCKD19 vs wild-type mice. Markers for renal inflammation and fibrosis were similarly attenuated in the CLOCKD19 mice given DOC/salt. Moreover, increased CLOCK expression in H9c2 cardiac cells enhanced MR-mediated transactivation of Per1, suggesting cooperative signaling between these transcription factors. This study demonstrates that the full development of MR-mediated cardiac inflammation and fibrosis is dependent on intact signaling by the circadian protein CLOCK.
I
nappropriate activation of the cardiac mineralocorticoid receptor (MR) promotes cardiac tissue inflammation and fibrosis, independent of changes in systolic blood pressure and renal electrolyte homeostasis (1) (2) (3) . MR activation in cardiomyocytes increases oxidative stress and recruitment of inflammatory cells to enhance the inflammatory process, which in turn promotes increased deposition of collagen in the resolution phase of the tissue inflammation (4) (5) (6) .
Current MR antagonists (MRAs) in clinical use have clear benefits for patients with all-cause heart failure, mild heart failure, or heart failure after infarction (7) (8) (9) .
However, although patient outcomes were significantly improved, the incidence of hyperkalemia after the Randomized Aldactone Evaluation Study and Eplerenone Heart Failure Efficacy and Survival Study remains high (7) (8) (9) . Targeted or selective therapies that provide the cardiac protection of MR antagonists, but preserve normal renal function, would have a potential advantage in the management of heart failure.
Numerous studies have sought to define the cellular pathways downstream of the MR that underpin the development of cardiac fibrosis (10) . Previous work from this laboratory using deoxycorticosterone (DOC) administration together with a moderate increase in dietary sodium (DOC/salt) showed that the cardiac tissue remodeling process following MR activation is driven by unique signaling pathways in cardiomyocytes, endothelial cells, and macrophages (11) ; however, it remains to be seen whether targeting cell-specific MR-dependent pathways will achieve the required therapeutic selectivity and improvements in side effect profiles.
One potential pathway linking MR signaling to downstream endpoints of inflammation and fibrosis is the intrinsic cardiac circadian clock. A central or "master clock" is located in the suprachiasmatic nucleus, constrained to a 24-hour periodicity by light signals via the optic nerve plus input from food intake and locomotor activity (12) . Autonomous circadian clocks in peripheral tissues are "entrained" by neurohormonal signals from the suprachiasmatic nucleus, including glucocorticoid secretion (12) . The circadian clock is a ubiquitously expressed transcriptional-translational negative feedback loop that allows a cell to anticipate time-of-day stimuli (13) . The positive arm is formed by a CLOCK: Bmal1 dimer that increases transcription of period (Per) and crytochrome (Cry). The negative arm consists of elevated levels of Per and Cry inhibiting the CLOCK: Bmal1 dimer; other circadian clock proteins serve to reinforce this "core" clock mechanism (13) .
Circadian gene products can also serve as transcription factors that regulate target genes, including those with a direct role in inflammation and fibrosis, for example, PAI-1, CTGF, fibronectin, collagens I and III, matrix metalloproteinases, and a range of inflammatory cytokines, including tumor necrosis factor (TNF)-a, interleukin (IL)-1, IL-1a, and IL-6 (14, 15) . Dysregulation of the anticipatory function of the circadian clock limits the capacity of a cell to adapt and respond appropriately to external stimuli (16) , and thus dysregulation of the circadian clock is linked to cardiovascular disease and adverse cardiac events, which show a strong circadian dependency (17) .
Glucocorticoid regulation of the peripheral molecular clock via activation of the glucocorticoid receptor (GR) is well established (18) (19) (20) (21) . However, recent studies suggest that the MR may also play a role in regulating the circadian clock in the heart (22, 23) . Aldosterone can directly induce transcription of Per1 and Per2 in cardiac cells, whereas mice null for the MR in cardiomyocytes do not regulate the circadian gene, Per2, in response to DOC/ salt (22, 23) . We therefore investigated the importance of circadian clock function in MR-mediated cardiac inflammation and fibrosis.
CLOCKD19 mice express a truncated CLOCK protein due to an A to T transversion, which prevents CLOCK: Bmal1 dimerization, as well as normal circadian transcription of Per, Cry, and other clock-controlled genes, and they thus lack an oscillating circadian clock (24, 25) . CLOCKD19 mice subjected to DOC/salt-mediated cardiac remodeling show that normal circadian clock signaling is required for the full pathogenesis of MR-mediated cardiac tissue remodeling. Moreover, we provide evidence that CLOCK and the MR may cooperate to regulate transcription of target genes.
Materials and Methods

DOC/salt model in CLOCKD19 mice
All procedures involving animals were approved by the Monash University Animal Ethics and Biosafety Committees. CLOCKD19 mice lack normal circadian oscillatory function in all cells, yet owing to their CBA/CaJ genetic background, which allows autonomous secretion of melatonin, they retain normal sleep/wake cycles (26) . All mice were maintained under 12-hour light/12-hour dark cycles (lights on at 8:00 AM, lights off at 8:00 PM), uninephrectomized, and given normal chow plus 1% saline to drink ad lib. Eight-week-old male CLOCKΔ19 mutant and CBA/CaJ mice [wild-type (WT)] were randomly assigned to receive no further treatment [vehicle (VEH)] or a 21-day slow release DOC pellet (50 mg, subcutaneously) that was replaced after 21 and 42 days (27) . Systolic blood pressure (SBP) was measured at 4 and 8 weeks in pretrained mice by tail-cuff plethysmography (IITC Life Science, Woodland Hills, CA). At 8 weeks, arterial blood was collected by cardiac puncture, and the heart and kidney were dissected and fixed (10% formalin in 0.1 M phosphate buffer solution (phosphate-buffered saline; pH 7.4) or rapidly snap frozen in liquid nitrogen. All mice were culled between 8:00 AM and 9:00 AM zeitgeber time (ZG) 0 and 1.
Serum hormone assays
Serum aldosterone was determined by enzyme-linked immunosorbent assay (ELISA; the aldosterone monoclonal antibody was a gift from Profs. C. and E. Gomez-Sanchez) (28) , whereas corticosterone and insulin were assessed by commercial radioimmunoassay or ELISA, respectively, according to the manufacturer's instructions (a 125 I radioimmunoassay kit from MP Biochemicals, Santa Ana, CA, and an insulin ELISA mouse/ rat insulin ELISA kit from Merck Millipore, Bayswater, VIC, Australia).
Immunohistochemistry for markers of inflammation
Cardiac inflammation was assessed by immunohistochemistry for the following markers: Mac-2 + macrophages (Gal-3; eBioscience 14-5301), CD3 + T cells (Abcam, Cambridge, UK), and osteopontin (MMPIIB101; Iowa University Hybridoma Bank, Iowa City, IA) with the relevant secondary antibody using an IgG negative control ( Table 1 ). The area of positively stained tissue was estimated, where the investigator was blinded to the identity of the samples, using the Analytical Imaging Station software package (version 4.0 beta 1.5, Imaging Research, St. Catherine's, ON, Canada).
Quantitative reverse transcription-polymerase chain reaction
Total RNA was isolated from heart and kidney using TRI Reagent (Sigma-Aldrich, St. Louis, MO) and Ambion DNA-free DNase treatment used to remove contaminating DNA following the manufacturer's instructions. Firststrand complementary DNA synthesis was performed using the Life Technologies SuperScript III first-strand synthesis kit (Invitrogen, Waltham, MA). Heart and kidney RNA was analyzed by BioMark HD digital polymerase chain reaction (PCR; Fluidigm) using TaqMan primer probes listed in Supplemental Table 1 . Fold change vs housekeeping gene was calculated for each sample using the DDCt method and normalized to values from the WT control-treated group.
Synthesis of the CLOCKD19 mutant expression and Per1 luciferase reporter vectors
Ten kilobases upstream of the Per1 transcriptional start site was assessed for glucocorticoid response elements (GREs) and e-boxes (response elements for circadian proteins) using the JASPAR database (http://jaspar.genereg. net). The 23867 to 23263 region of the Per1 promoter was selected for further validation because it contained two GREs and four e-boxes. This 604-bp region was isolated by PCR of genomic DNA using primers 5 0 -TCGGGAGTC-CATGGGTTTGC-3 0 (forward) and 5 0 -AATTATGGCGC-CAAGACTGG-3 0 (reverse) and subcloned into the pGL3 basic luciferase reporter vector (Promega, Madison, WI), using HindIII and NcoI restriction sites. The pCM4 (CLOCK no. 31366) expression vector (a gift from Dr. Aziz Sanchal, AddGene, University of Maryland) was used in its native form and modified by digestion with HindIII and NcoI, and religated to generate a truncated CLOCK protein similar to the CLOCKD19 mutation. pRshMR was a gift from Prof. Ron Evans. All plasmids were validated by sequencing.
Luciferase reporter assay in H9c2 cells
H9c2 rat cardiac cells (American Type Culture Collection) were seeded at 40,000 cells per well in a 24-well plate and transiently transfected with expression vectors as follows: 200 ng of full-length human MR (pSRhMR) (29) and 200 ng of Bmal, WT CLOCK or CLOCKD19 plus 200 ng of Per1 luciferase reporter construct using FuGene (Promega) in complete media. After 24 hours, media was replaced with media containing 7% charcoal-stripped serum for 2 hours and cells were pretreated with 1 mM potassium canrenoate or vehicle for 30 minutes before the addition of 10 nM aldosterone (SigmaAldrich). Cells were incubated overnight and luciferase activity was measured as previously described (29) 
Statistical analysis
Statistical analysis for all data sets were performed using GraphPad Prism 6.2 software package (GraphPad Software, La Jolla, CA) and analyzed using two-way analysis of variance (ANOVA) and the Bonferroni post hoc test with correction for multiple comparisons to identify significant differences between groups. All data are presented as means 6 standard error of the mean (SEM). There were n = 7 to 10 animals per group, and P values are annotated as *P , 0.05, **P , 0.01, and ***P , 0.001.
Results
The CLOCKD19 model of circadian clock dysfunction CLOCKΔ19 mice were heavier than WT CBA mice irrespective of treatment. However, plasma levels of insulin were lower in CLOCKD19 mice, as has been previously reported (30) , and moreover they were unaffected by DOC/ salt treatment. Aldosterone and corticosterone were within the expected range for mice drinking 1% saline (Table 2) . Cardiac and kidney weight, as a function of tibia length, were higher in CLOCKΔ19 mice regardless of treatment. Net cardiac tissue fibrosis, determined by Sirius red staining, was modestly increased in CLOCKΔ19 mice at baseline; cardiac macrophage and T cell numbers (CD3 + cells) were also elevated in CLOCKΔ19 mice receiving vehicle ( Table 2) . Cardiac tissue fibrosis in response to DOC/salt is reduced in CLOCKD19 mice DOC/salt for 8 weeks produced a significant increase in fibrosis in WT mice (twofold vs WT VEH) as previously shown (6); however, the fold increase in tissue fibrosis following DOC/salt treatment was significantly lower in CLOCKD19 mice (1.2 fold vs CLOCKD19 VEH; Fig. 1A ). Consistent with these data, we detected lower levels of myofibroblast marker a smooth muscle actin (aSMA) and integrin B1 messenger RNA (mRNA) levels were detected in the hearts of CLOCKD19 DOC mice compared with WT DOC mice after DOC/salt (Figs. 1 and 2; Supplemental Table 2 ), whereas transforming growth factor (TGF)-b levels were unchanged (data not shown). Expression of matrix metalloproteinase (MMP)-2 and MMP-9 was significantly elevated in CLOCKD19 DOC hearts, and the ratio of MMP-9 to TIMP1 mRNA, an indicator of MMP-9 activity, was significantly higher in CLOCKD19 hearts at baseline and after DOC/salt, suggesting a increased turnover of the extracellular matrix (Figs. 1 and 2; Supplemental Table 2 ) (23). In contrast, levels for Col1a and Col3a mRNA in whole heart homogenate were markedly elevated in response to DOC/salt in the CLOCKD19 mouse but not in WT mice (Supplemental Fig. 1 ; Supplemental Table 2 ).
DOC/salt-mediated cardiac inflammation is blunted in CLOCKD19 mice
DOC/salt induced a significant increase in macrophage and T cell recruitment in WT hearts ( Fig. 1;  Supplemental Fig. 1) . Baseline values for cardiac tissue macrophage and CD3 T cell numbers were elevated in CLOCKD19 VEH mice vs WT VEH mice; however, DOC/salt only modestly increased macrophage and T cell recruitment in CLOCKD19 mice compared with the response in WT hearts (Table 2 ). CLOCKD19 DOC hearts also showed lower mRNA levels for adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and Vcan vs WT; however, DOC/salt treatment increased expression similarly in WT and CLOCKD19 hearts (Supplemental Fig. 1 ; Supplemental Table 2 ).
mRNA levels for macrophage and T cell chemoattractant factors MCP-1, CXCL9, CXCL10, CCL5, and CCR5 were significantly lower in hearts of CLOCKD19 mice. We also detected a reduction in cardiac tissue inflammation in CLOCKD19 mice in general; mRNA levels for TNF-a, fractalkine (CX3CL1) and its receptor (CX3CR1), and inflammatory proinflammatory transcription factors RelA and RelB were lower in CLOCKD19 vs WT mice regardless of treatment ( Fig. 1 ; Supplemental Fig. 1 ; Supplemental Table 3 ).
CLOCKD19 mice have an enhanced cardiac hypertrophic response to DOC/salt
Cardiac weight corrected for tibia length was increase for both WT and CLOCKD19 mice given DOC/salt; however, CLOCKD19 mice showed a proportionally greater increase in cardiac weight than for WT mice given DOC/salt ( Table 2) . Markers of cardiac hypertrophy BNP and ANP mRNA levels were also elevated by Table 2 ). Of note, indices of cardiac size increased in CLOCKD19 mice despite a significantly reduced SBP response in these mice (Table 2) . Importantly, the SBP and cardiac hypertrophy responses were not concordant, suggesting direct regulation of cardiac hypertrophy by combined MR and the circadian clock-regulated PTEN-AKT hypertrophic signaling pathway (31) . Moreover, immunostaining for osteopontin showed a strong treatment effect in cardiomyocytes in response to DOC/salt in both WT and CLOCKD19 mice, consistent with the cardiac tissue mRNA levels for osteopontin (Supplemental Fig. 1 ; Supplemental Table 2 ).
Eight weeks of DOC/salt does not regulate net circadian clock gene expression in hearts at the activity-rest transition Regulation of the expression of all circadian genes was assessed in heart tissue collected at ZG0 (8:00 AM, lights on) to identify any changes in circadian clock gene levels. Cardiac expression of "core" circadian clock genes (CLOCK, Bmal1, Per, and Cry) was not altered by 8 weeks of DOC/salt at ZG0 in WT or CLOCKD19 mice (8:00 AM; Fig. 2 ; Supplemental Table 4 ). The exception was the "noncore" circadian gene D site of albumin promoter (albumin D-box) binding protein (DBP). Both baseline mRNA levels and DOC/salt induction of DBP were significantly lower in CLOCKD19 mice vs WT mice ( Fig. 1; Supplemental Fig. 1 ; Supplemental Table 4) . DOC/salt excess suppressed transcripts for cardiac Reverb-a (NR1D1) mRNA, the CLOCK-controlled gene nuclear factor, IL-3 regulated (NFIL3/E4BP4), and NPAS2 in WT but not CLOCKD19 hearts. A genotype effect was detected by two-way ANOVA for Bmal1, Per1 and Per2, Cry2 and PPARg, for which mRNA levels were lower in CLOCKD19 hearts vs WT. In contrast to our previous studies in C57BL6/J mice, cardiac MR expression was significantly decreased in response to DOC/salt treatment in WT (CBA/CaJ) hearts but not in CLOCKD19 mutant tissue (Supplemental Table 4 ). GR mRNA levels were also suppressed in response to DOC/salt, but only in WT hearts ( Fig. 2 ; Supplemental Fig. 1 ; Supplemental Table 4 ).
Renal fibrosis and inflammation are also reduced in CLOCKD19 mice
Renal fibrosis and tissue remodeling were assessed by reverse transcription PCR. DOC/salt treatment significantly elevated several profibrotic markers in the remaining kidney from mice of both genotypes: fibroblastspecific protein-1, osteopontin, CTGF, PAI-1, Col1a, and Col3a ( Fig. 3 ; Supplemental Table 5 ). However, the TGFb/CTGF inhibitor decorin was higher and the profibrotic factor MMP-12 was significantly lower in kidneys from DOC/salt-treated CLOCKΔ19 mice compared with WT mice (Supplemental Fig. 2 ; Supplemental Table 5 ), suggesting inhibition of profibrotic mediators. Kidney weight corrected for tibia length was higher in CLOCKD19 mice vs WT, regardless of treatment, consistent with the hypertrophic response detected for the heart (Table 2) .
Markers for T cells, B cells, macrophages/monocytes, and lymphocytes were all significantly decreased in CLOCKD19 mice compared with WT. mRNA for chemoattractant factors CCL2 and CCL5 and their receptors CCR2 and CCR5 were also significantly lower in CLOCKD19 kidney tissues, regardless of treatment, indicating a reduced inflammatory response overall; T cell receptors and their ligands CXCL9 and CXCL10 were also markedly reduced in CLOCKD19 mouse hearts ( Fig. 3; Supplemental Fig. 2 ; Supplemental Table 6 ). Similarly, expression of chemoattractant factors intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 were lower in CLOCKD19 DOC/ salt-treated kidneys compared to WT DOC/salt-treated tissues (Supplemental Table 5 ).
Similar to the heart, the inflammatory profile in kidneys following DOC/salt treatment was reduced in CLOCKD19 mice vs WT; TNF-a, IL-1b, and IL-6 were significantly lower in the CLOCKD19 mice compared with the WT mice (Supplemental Table 6 ). Oxidative stress markers (i.e., Nox2, Nos2, and p22phox) were also significantly lower in CLOCKD19 mice, whereas Nos3 was equivalent for both genotypes (Supplemental Fig. 2 ; Supplemental Table 6). A decrease in the recruitment of infiltrating inflammatory cells together with a significant attenuation of the inflammatory response may underpin the lower tissue remodeling response to DOC/salt in the CLOCKD19 mice.
We also investigated markers of renal sodium and volume regulation. The sodium potassium ATPase 1 (ATP1a) showed a genotype effect by two-way ANOVA, whereas the renal vasopressin target aquaporin 2 and arginine vasopressin receptor showed a treatment effect by two-way ANOVA in response to DOC/salt. An interaction was detected for the expression of AGTR2, but angiotensin type 1 receptors 1 and 2 showed no change. In contrast, expression of the b and g subunits of the ENaC receptor were similar for WT and CLOCKD19 in unchallenged mice, but DOC/salt treatment produced a significantly greater increase in their gene expression profile in the mutant mice (Supplemental Fig. 2 ; Supplemental Table 8 ).
Expression of circadian clock genes in the kidney
Kidney mRNA levels for circadian clock genes and clock-controlled genes in response to DOC/salt were equivalent to values detected in the heart for all genes except for Cry1 and Cry2. DOC/salt treatment increased Cry1 and decreased Cry2 expression in CLOCKD19 mice, but not in WT mice, suggesting a potential tissue-specific phase shift in gene transcription ( Fig. 2; Supplemental Fig. 2 ; Supplemental Table 7 ). In contrast to the heart, a genotype effect was detected for deleted in esophageal cancer 1 and Reverb-a mRNA levels in the kidney (Supplemental Table 3). Expression of CLOCK in whole kidney showed a pattern of response distinct to the heart where net values were increased in CLOCKD19 mice vs WT at 8:00 AM ( Fig. 3; Supplemental Fig. 2 ; Supplemental Table 7 ). Tables 2  and 7. doi: 10.1210/en. https://academic.oup.com/endoSIRT1 and casein kinase 1« are important posttranslational modifiers of CLOCK and Bmal1 proteins. SIRT1 mRNA levels were unchanged in both heart and kidney for treatment and genotype, whereas casein kinase 1« expression was markedly upregulated in the kidney but not the heart (Supplemental Tables 4 and 8 ).
MR and CLOCK cooperation to regulate Per1 gene transcription in cardiac cells
To determine whether MR and CLOCK cooperate to regulate other molecular clock genes in the heart, a luciferase reporter under the control of a Per1 promoter element containing 1 canonical GRE was assessed in H9c2 cardiac cells. Aldosterone (10 nM) significantly increased Per1 transcription, whereas cotreatment with the antagonist potassium canrenoate returned values to levels not different from those of VEH (Fig. 4A) . Overexpression of the CLOCK protein resulted in an additive increase in the transcription of Per1 in the presence of 10 nM aldosterone, and coadministration of an MR antagonist blocked this response (Fig. 4A) . Per1 has previously been described as an MR response gene and is dysregulated in CLOCKD19 mice. Expression of Per1 in cardiac cells oscillates during 24 hours following serum shock and is phase advanced in the presence of corticosterone or aldosterone (Fig. 4B) . The remaining clock genes were predominantly regulated by serum shock and showed minimal regulation by coadministration of corticosterone or aldosterone (Supplemental Figs. 1 and 2 ; Supplemental Tables 4 and 8) .
Discussion
This study demonstrates that the full development of MR-mediated cardiac inflammation and fibrosis is dependent on functional circadian CLOCK signaling. Absence of the fundamental CLOCK signaling mechanism is sufficient to limit MR pathological signaling pathways and suggests an interaction between the two signaling systems in cardiac inflammation and fibrosis and cardiac hypertrophy. However, although baseline cardiac expression of inflammatory cytokines and chemoattractant factors was lower in CLOCKD19 mutant mice, cardiac hypertrophy was increased. Moreover, blood pressure remained normal in CLOCKD19 mutant mice. Our data therefore support previous studies from this laboratory, and elsewhere, showing a central role for macrophages in the onset of cardiac fibrosis and a disconnect between SBP and cardiac size. Moreover, we now provide in vitro evidence that the MR may interact with a core circadian transcription factor, CLOCK, to modify transcriptional responses in a cardiac cell line. 
Regulation of MR-dependent tissue inflammation and fibrosis by the circadian clock
The present study clearly shows that the characteristic response to an 8-week DOC/salt challenge in CLOCKD19 mutant mice is blunted, suggesting that the circadian clock has a regulatory or permissive role in MR-mediated tissue remodeling. One mechanism that may be involved is modification of the activation of the infiltrating macrophages. Once recruited to the tissue, macrophages and T cells release chemoattractants and proinflammatory cytokines, which further enhance inflammatory cell recruitment and tissue inflammation, thus promoting further fibrosis. Many markers were significantly lower in hearts and kidneys from CLOCKD19 mutant mice vs WT mice given DOC/salt. Although circadian control of inflammation has been demonstrated in a number of elegant studies highlighting diurnal control of Toll-like receptor signaling and the inflammasome (32-34), MR regulation of nonoscillating genes (e.g., aSMA, FGF2, osteo, PDGFRb, Mac2, integrin B1) in the current study indicates that changes in gene expression are not due to random changes in their diurnal rhythm.
Elevated remodeling responses in unchallenged mice with a disrupted circadian clock are consistent with previous reports (30, 35) and may reflect elevated expression of proinflammatory cytokines in response to low or absent transcriptional regulation by "antiinflammatory" members of the circadian clock. For example, when Bmal1 is inactive, as is the case in CLOCKD19 mutant mice, CXCL9 expression is elevated (36) . Similarly, a functional molecular clock is required for Reverb-a, a known modulator of inflammation. Overexpression of Reverb-a is can decrease inflammation via modulation of nuclear factor kB (NF-kB), IL-6, and MCP-1, and suppress PAI-1 (37, 38) . In contrast, our data do not support a role for increased MR activation in driving the higher baseline values in CLOCKΔ19 mice. Serum aldosterone and corticosterone levels are equivalent for WT and CLOCKΔ19 mice with VEH treatment, and genes previously associated with MR activation in cardiac/renal fibrosis are unchanged in CLOCK control vs WT VEH. MR blockade in CLOCKΔ19 mice is required to directly address this point.
Many circadian clock genes have been implicated in the promotion of inflammation and fibrosis (15, 39) ; CLOCK and Bmal1 can promote fibrosis via transcriptional control of PAI-1, TGF-b, CTGF, COX-2, VEGF, and its receptor Flit1, and indirect regulation of MMPs, which serve to not only control ECM turnover but also activate growth factors, including VEGF (40) . A recent study indicated that CLOCKD19 mutant mice have elevated expression of the NF-kB RelB subunit; in contrast to classic NF-kB signaling, RelB limits inflammation (41) . This may reflect an internal limiting mechanism for elevated inflammatory processes in unchallenged CLOCKD19 mutant mice, and it may contribute to the blunted tissue response to the DOC/salt challenge. We also detected decreased levels of markers of oxidative stress NOX2 and p22phox, suggesting that the normal CLOCK signaling is required for their regulation by MR activation.
Although the primary focus of the present study was to investigate the requirement for circadian signaling in MR-mediated cardiac fibrosis, we also investigated responses in the kidney to identify overlapping and distinct responses related to tissue remodeling. We did find a common reduction in the inflammatory response for heart and kidney, although the inflammatory gene set investigated in each tissue showed an overlapping but unique set of genes. Taken together, the data support the concept that inflammatory responses are blunted in CLOCKD19 mice.
A role for MR signaling in the transcriptional control of circadian clock genes Disruption of circadian clock function in the mutant mice has an impact on virtually all members of the circadian signaling system (42) . In this study, we investigated the combined response to CLOCKD19 and MR activation of cardiac circadian clock; expression of Bmal1 and Cry1 and Cry2 genes was lower for CLOCKD19 mice, whereas Per1 and Per2 were significantly elevated. Although elevated Per1 and Per2 levels in CLOCKΔ19 mutant mice have been previously described, these data were obtained at the nadir of Per expression, more likely reflecting oscillating gene expression in WT mice vs mutant mice, in which gene expression remains unchanged (42, 43) . The enzyme CSNK1« acts to phosphorylate and stabilize both the Per family of genes (44) and Bmal1, thereby reinforcing the period of oscillation, which in turn can modify the overall period and phase of the circadian clock (45) (46) (47) . Our data show no change in CSNK1« expression in the hearts of CLOCKD19 mutant mice at ZG0 but increased expression in the kidney following DOC/salt treatment ( Fig. 2 ; Supplemental Figs. 1 and 2; Supplemental Tables  4 and 8) .
In contrast to core circadian genes, MR activation modified expression of a subset of noncore circadian genes. DBP was significantly elevated by DOC/salt in both the heart and kidney regardless of genotype; however, baseline values were lower for CLOCKD19 mutant mouse tissues and the fold change was greater for WT mice, suggesting that an intact circadian clock is required for a full tissue response. The CLOCK homolog Timeless was also upregulated by DOC/salt treatment, but responses varied between tissues and genotype, suggesting that other contributing factors may be modifying its regulation between tissues.
Cardiac remodeling and hypertrophy are independently regulated by circadian dysfunction
An interesting finding in this study was the different regulation of cardiac inflammation, fibrosis, and hypertrophy by loss of circadian signaling. Whereas proinflammatory cytokine signaling and fibrosis were blunted in transgenic animals, cardiac weight was significantly higher in CLOCKD19 circadian-disrupted mice and increased further by DOC/salt treatment. The circadian clock has been previously linked to cardiac weight and pathological hypertrophy, and these new data show an exaggerated response to MR activation by DOC/salt, consistent with these previous reports (48, 49) . Mice in which Bmal1 is selectively deleted from the heart demonstrate left ventricular hypertrophy, which worsens with age. These studies also suggested that this was in part due to disorganized sarcomeres (48) . In contrast to the pathophysiological hypertrophy seen in Bmal1-null mice, a healthy hypertrophy is seen in Per2 mice after myocardial infarction (50) . These data underscore the independent development of cardiac fibrosis and inflammation, which is often thought to be secondary to tissue hypertrophy rather than a direct effect of MR signaling in a unique set of cells. Moreover, cardiac tissue hypertrophy was independent of SBP, which was significantly lower in CLOCKD19 mice given DOC/salt. Our data also do not support a direct role for MR signaling in the inflammatory/fibrotic response observed in the heart; MR target genes and those associated with DOC/salt fibrosis were similar for WT VEH and CLOCK VEH, whereas DOC/salt increased a subset of genes in WT mice only. The use of MRA in CLOCKD19 mice will be interesting to determine whether any aspects of disease due to circadian disruption can be prevented.
The circadian signaling system plays a key role in determining the overall responsiveness of cardiomyocytes to environmental stimuli. Rhythmicity, ion homeostasis, and metabolic and other pathways are under the control of the cellular circadian clock (51) . Metabolic pathways required for generation of ATP in particular are also influenced by whole-body metabolic status. Despite the CLOCKD19 mice being heavier overall compared with WT mice, we confirmed that this model has lower plasma insulin levels, thereby limiting a key circulating factor that could modulate cardiac tissue metabolic pathways (52) .
Interaction between circadian clock dysfunction and DOC/salt SBP regulation Consistent with previous reports, unchallenged CLOCKD19 mutant mice showed no differences in baseline SBP (53, 54) . However, loss of circadian clock signaling results in lower SBP after 8 weeks of DOC/salt administration. Previous studies have implicated many circadian clock genes in the regulation of SBP, although the specific outcome can vary considerably (52, (55) (56) (57) . Bmal1 knockout mice are unique in that under normal conditions, they have decreased SBP, predominantly via loss of the diurnal variation in their SBP (53) . Cry-null mice are normotensive under normal conditions, yet they display salt-sensitive hypertension due to overexpression of HSD3b6 in the adrenal cortex and overexpression of aldosterone (56) . Sodium handling may also be regulated by Per1 that may regulate the ENaC a subunit, although these studies used supraphysiological levels of aldosterone (58, 59) . Sodium handling in CLOCKΔ19 mutant mice has not been explored. Moreover, CLOCKD19 mice do not produce AVP, and this will have a significant impact on SBP as demonstrated in several models of hypertension (60) .
Cooperative transcriptional control by the MR and CLOCK can modify Per1 signaling
Our data show that the MR can act cooperatively with CLOCK at the Per1 promoter to modify transcriptional responses, providing a proof of principle that these two signaling pathways can converge to regulate a target gene promoter. It is recognized that MR/aldosterone regulation of circadian rhythms may be influenced by fluctuating hormone levels during a 24-hour period, and this will include cortisol/corticosterone, which have a strong circadian expression pattern and can bind the MR in cardiomyocytes and monocytes/macrophages due to the absence of HSD2 in these cell types. These data therefore support a direct mechanism whereby MR signaling outcomes can vary during the course of the day. Equally, in the setting of adrenal disease or hypertension, where corticosteroid levels do not follow a circadian pattern of release, interaction with the circadian transcriptional machinery may have important implications for the development and outcome of diseases for which dysregulation of the circadian clock has been described. However, the potential for MR modification of this fundamental cell signaling system, and vice versa, remains to be defined in full. Importantly, note that whereas cortisol signaling via the GR is a known "time keeper" of the circadian clock in peripheral tissues, studies have not always demonstrated a role for the GR, and the MR may thus play a fundamental role in modifying peripheral clock function. The concept that MR signaling may interact with CLOCK to regulate target genes has been previously demonstrated for the GR and Bmal1 and indicates a novel mechanism whereby corticoid hormones and their receptors can regulate circadian and potentially other genes (61).
Conclusions
We have shown that MR-mediated cardiac inflammation and fibrosis is dependent on a functional CLOCK, a core member of the circadian clock signaling system. Given that MR signaling may act together with the circadian clock to modify gene transcription in an additive fashion, and that loss of normal CLOCK signaling limits MRmediated cardiac pathology, the cellular circadian clock may offer therapeutic options for treating MR-dependent cardiac inflammation and remodeling. However, a full understanding of the cell-specific interactions of MR signaling with the circadian clock will be required given the need to balance the protective effects of a reduced inflammatory/fibrotic response with the potential for cardiac hypertrophy in circadian-disrupted animals. Moreover, the role of the oscillatory circadian machinery in driving the MR-dependent cardiac response requires further evaluation given the potential for other circadian disrupted models to produce unique cardiac phenotypes.
The negative impact of a dysregulated circadian clock is most clearly seen in rotating shift workers and those who regularly work through different time zones. These individuals have significantly higher rates of cardiovascular disease, diabetes, and metabolic disorders than for the general population (16) . Whether MRA use in these patients has specific benefits is unknown, but a better understanding of the cellular mechanisms that underpin the poorer outcomes for cardiovascular disease in circadian-disrupted subjects may enable better screening and appropriate treatment of those patients at greatest risk.
